The Scientific Advisory Board

The remit of the Board is to:

ensure that applications meet the Ipsen Fund's aims

ensure that the focus of applications relates to diseases or treatments with an endocrine or neurological basis.

make reasoned, independent, and unbiased decisions on funding awards

Applicants should be aware that any decision made by the Scientific Advisory Board is final and no correspondence will be entered into.

Who is on the Board?

The Board includes three academically distinguished clinicians, all internationally recognised as leaders in their field. The current Scientific Board members are:

	Professor Michael Sheppard Pro-Vice-Chancellor William Withering Professor of Medicine University of Birmingham
	Dr John Reynard Consultant Urological Surgeon Churchill Hospital Oxford
	Dr Chris Clough Consultant Neurologist Kings College Hospital London